SCHEMBL6237016

SCHEMBL6237016

CC(C)(C)COB(OCC(C)(C)C)B(OCC(C)(C)C)OCC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9512818 0.73
Ethylene Glycol SCHEMBL4902379 0.66
SCHEMBL18191 0.65 CYP2C19 (0.42) CYP2C19
SCHEMBL8029850 0.65 CYP2C19 (0.42) CYP2C19
Cyclohexane SCHEMBL3216822 0.64 CYP2C19 (0.36) CYP2C19
SCHEMBL90415 0.62
Hydrochloric Acid SCHEMBL8858515 0.62 CYP2C19 (0.40) CYP2C19
SCHEMBL7672181 0.59
SCHEMBL13917610 0.59
SCHEMBL7936533 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052522-A1 Boronic compounds COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION 2002-05-02 US claimed
US-6346639-B1 Boronic compounds THE COMMONWEALTH OF AUSTRALIA COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) 2002-02-12 US claimed
EP-1121365-B1 ORGANOBORON DERIVATIVES AND PROCESS FOR COUPLING ORGANIC COMPOUNDS COMMW SCIENT IND RES ORG (AU) 2005-06-08 EP disclosed
US-6713566-B1 CATALYTIC HYDROBORATION OF OLEFINIC OR ACETYLENIC FUNCTIONA-LIZED MATERIAL UNDER MILD CONDITIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-03-30 US disclosed
US-6515160-B2 Boronic compounds COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2003-02-04 US disclosed
EP-1056751-A4 BORONIC COMPOUNDS COMMW SCIENT IND RES ORG (AU) 2003-01-22 EP disclosed
US-20020052522-A1 Boronic compounds COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION 2002-05-02 US disclosed
US-6346639-B1 Boronic compounds THE COMMONWEALTH OF AUSTRALIA COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) 2002-02-12 US disclosed
EP-1056751-A1 BORONIC COMPOUNDS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2000-12-06 EP disclosed
WO-1999033845-A1 BORONIC COMPOUNDS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1999-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052522-A1 Boronic compounds NR0B2, NR4A1, NR0B1 CYP2C19 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.